ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 113053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 113053; 2) Community: the network communities that were significantly associated with the response to NSC 113053; 3) Molecule: the relationships between components within communities and NSC 113053; 4) MDR: the compounds that were significantly associated with the NSC 113053.

NSC Compound Enrichment Correlation
NSC 100290 Doxypyrromycin hydrochloride 0.011544784012433 0.091560351
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.0115447840124334 0.23083092
NSC 374028 Camptothecin Derivative 0.0115447840124334 0.22426556
NSC 38086 Null 0.0115447840124334 0.21223774
NSC 606498 Camptothecin Derivative 0.0115447840124334 0.090643542
NSC 610458 Camptothecin Derivative 0.0115447840124334 0.16595038
NSC 621322 Null 0.0115447840124334 0.013968071
NSC 639174 Camptothecin Derivative 0.0115447840124334 0.15451558
NSC 639186 Raltitrexed 0.0115447840124334 0.045716777
NSC 640499 2,2':6',2"-Terpyridine, 4'-[4-(2-hydroxyethoxy)phenyl]- 0.0115447840124334 0.22776233
Total:60  Current:17    [First] [Prev] [Next] [Last]